Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 41 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Reduced Intensity Transplant Using Extracorporeal Photopheresis				Phase II, Phase I				ECP RIT NCT00179790
	Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors				Phase II, Phase I				BMT 0499 Solid NCT00179816
	Aerosol L9-NC and Temozolomide in Ewing's Sarcoma				Phase II, Phase I				2005-0889 NCT00492141
	Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors				Phase II, Phase I				A4021020 NCT00560235
	Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer or Other Solid Tumors				Phase II				WSU-2007-033 NCT00020722, RWMC-0634246
	Chemotherapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Young Patients With Recurrent Sarcoma				Phase II				NCI-02-C-0259H NCT00047372
	Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma				Phase II				SARC003 NCT00073983, NCI-04-C-0001, AEWS0421, MAYO-79-2003
	Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases				Phase II				PSCI-2003-232 NCT00084695
	Radiation Therapy to Treat Musculoskeletal Tumors				Phase II				RTSARC NCT00186992
	Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors				Phase II				MSKCC-05059 NCT00357396


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute